Related by context. Frequent words. (Click for all words.) 70 Phase 2b trial 70 dosing regimens 70 Phase 1b 69 evaluable patients 69 Phase Ib 68 Phase 2b study 68 dose escalation 67 mg dose 66 Phase 2a 66 Phase IIa trial 66 mg BID 65 mg doses 65 IMGN# 65 dose limiting toxicities 65 evaluable 64 pharmacodynamic 64 MGCD# [001] 64 multiple ascending dose 64 Phase 2b clinical 63 dose escalation study 63 monotherapy 63 INCB# [002] 63 CYT# 63 antitumor activity 63 Phase 2b 63 eculizumab 63 dose regimen 63 tolerability 63 randomized Phase 63 docetaxel 62 plus ribavirin 62 RDEA# 62 RG# [001] 62 mipomersen 62 dasatinib 62 pivotal Phase III 62 AP# [003] 62 Phase IIa clinical 62 XL# [003] 62 pharmacokinetic profile 62 TMC# [001] 62 mg/m2 62 Phase IIb 62 sunitinib 62 HspE7 62 ISIS # 61 blind randomized placebo 61 pharmacodynamics 61 Phase III trials 61 pivotal Phase 61 ofatumumab 61 Phase IIb trial 61 Phase IIa 61 T DM1 61 Phase III clinical trials 61 Phase 2a clinical 61 Phase III clinical 61 pegylated interferon 61 placebo controlled 61 randomized placebo controlled 60 MDV# 60 IDX# 60 relapsing remitting multiple sclerosis 60 tolerability profile 60 Phase IIb clinical 60 pharmacokinetic 60 gemcitabine 60 Zenvia 60 sitagliptin 60 PMX # 60 bortezomib 60 safety tolerability 60 free survival PFS 59 tumor shrinkage 59 tumor regression 59 fludarabine 59 double blind placebo 59 ALKS 59 carfilzomib 59 panitumumab 59 Perifosine 59 antiviral activity 59 FTY# 59 JANUVIA 59 Phase III 59 FOLFOX 59 randomized 59 ZYBRESTAT 59 FOLOTYN 59 temozolomide 59 febrile neutropenia 59 raltegravir 59 rituximab 59 ARRY 59 plasma concentrations 59 cytarabine 59 LymphoStat B 59 laquinimod 59 Locteron 58 telbivudine 58 AZD#